These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33423125)

  • 21. ASO Author Reflections: Gastric Cancer with Synchronous Peritoneal Disease-A Clinically Meaningful Survival After CRS and HIPEC in Selected Patients from Italian Peritoneal Surface Malignancies Oncoteam Network.
    Marano L; Marrelli D; Roviello F
    Ann Surg Oncol; 2021 Dec; 28(13):9071-9072. PubMed ID: 34018086
    [No Abstract]   [Full Text] [Related]  

  • 22. ASO Author Reflections: Standardizing HIPEC Methodology and Regimens: a Prelude to the PSOGI Expert Consensus.
    Bhatt A; Van Der Speeten K; Hubner M; Kusamura S; Glehen O
    Ann Surg Oncol; 2021 Dec; 28(13):9114-9115. PubMed ID: 34089108
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status.
    Hanna DN; Magge D
    Ann Surg Oncol; 2022 Jan; 29(1):260-261. PubMed ID: 34455512
    [No Abstract]   [Full Text] [Related]  

  • 24. ASO Author Reflections: Clinical Research and Application Prospect of HIPEC Combined with Surgery in Advanced Gastric Cancer.
    Zhang JF; Lv L; Zhao S; Zhou Q; Jiang CG
    Ann Surg Oncol; 2022 May; 29(5):3187-3188. PubMed ID: 35181814
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: Is it Correct to Use 5% Dextrose Solution as a Carrier Fluid for Oxaliplatin-based HIPEC?
    Park EJ; Hwang SJ; Baik SH
    Ann Surg Oncol; 2022 Dec; 29(13):8593-8594. PubMed ID: 36001184
    [No Abstract]   [Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.
    Zhou S; Jiang Y; Liang J; Pei W; Zhou Z
    World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflections: Delayed Occurrence and Postoperative Risks of Mitomycin-C-Induced Neutropenia After Hyperthermic Intraperitoneal Chemotherapy.
    Park EJ; Lee SJ; Baik SH
    Ann Surg Oncol; 2022 Mar; 29(3):2087-2088. PubMed ID: 34689262
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Scoping Review.
    Balachandran R
    Ann Surg Oncol; 2022 Sep; 29(9):6084-6085. PubMed ID: 35190947
    [No Abstract]   [Full Text] [Related]  

  • 29. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience.
    Nikiforchin A; Gushchin V; King MC; Baron E; Nieroda C; Sittig M; Sardi A
    J Surg Oncol; 2021 Mar; 123(4):1030-1044. PubMed ID: 33524164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy.
    Cascales Campos P; Martinez Insfran LA; Wallace D; Gil J; Gil E; Gonzalez Gil A; Martínez J; Alonso Romero JL; Gonzalez Sanchez R; Parrilla P
    Clin Transl Oncol; 2020 Jun; 22(6):852-859. PubMed ID: 31392644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASO Author Reflections: Major Late Complication Rates are Higher for Patients Who Underwent Iterative CRS\HIPEC When Compared to a Singular Procedure.
    Bekhor E; Magge D
    Ann Surg Oncol; 2020 May; 27(5):1456-1457. PubMed ID: 32124124
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up.
    Malekzadeh P; Good M; Hughes MS
    Int J Hyperthermia; 2021; 38(1):326-331. PubMed ID: 34139940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
    Zambrano-Vera K; Sardi A; Lopez-Ramirez F; Sittig M; Munoz-Zuluaga C; Nieroda C; Gushchin V; Diaz-Montes T
    Ann Surg Oncol; 2021 Aug; 28(8):4655-4666. PubMed ID: 33393042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    King BH; Baumgartner JM; Kelly KJ; Marmor RA; Lowy AM; Veerapong J
    PLoS One; 2020; 15(12):e0243252. PubMed ID: 33270763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Baumgartner JM; Kwong TG; Ma GL; Messer K; Kelly KJ; Lowy AM
    Ann Surg Oncol; 2016 May; 23(5):1609-17. PubMed ID: 26678406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASO Author Reflections: Neoadjuvant Chemotherapy for High-Grade Appendiceal Neoplasms Before Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Closer to Evidence-Based Practice?
    Mangieri CW; Levine EA
    Ann Surg Oncol; 2022 Apr; 29(4):2649-2650. PubMed ID: 35001235
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Lee ZJ; Teo CCM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):757-758. PubMed ID: 30374919
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.